Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02874742
Title Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham Alabama United States Details
Duarte California United States Details
La Jolla California United States Details
Los Angeles California United States Details
San Francisco California United States Details
Aurora Colorado United States Details
Washington District of Columbia United States Details
Orlando Florida United States Details
Tampa Florida United States Details
Atlanta Georgia United States Details
Chicago Illinois United States Details
Westwood Kansas United States Details
New Orleans Louisiana United States Details
Baltimore Maryland United States Details
Boston Massachusetts United States Details
Worcester Massachusetts United States Details
Detroit Michigan United States Details
Saint Louis Missouri United States Details
Omaha Nebraska United States Details
Buffalo New York United States Details
New York New York United States Details
Chapel Hill North Carolina United States Details
Charlotte North Carolina United States Details
Durham North Carolina United States Details
Winston-Salem North Carolina United States Details
Columbus Ohio United States Details
Portland Oregon United States Details
Abington Pennsylvania United States Details
Philadelphia Pennsylvania United States Details
Nashville Tennessee United States Details
Dallas Texas United States Details
Houston Texas United States Details
Salt Lake City Utah United States Details
Seattle Washington United States Details
Spokane Washington United States Details
Milwaukee Wisconsin United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field